Nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
and	O
AP-1	B-protein
are	O
insufficient	O
for	O
IL-2	B-DNA
promoter	I-DNA
activation	O
:	O
requirement	O
for	O
CD28	B-protein
up-regulation	O
of	O
RE/AP	B-protein
.	O

IL-2	B-protein
gene	O
transcription	O
in	O
T	B-cell_type
cells	I-cell_type
requires	O
both	O
TCR	O
and	O
costimulatory	O
signals	O
.	O

IL-2	B-DNA
promoter	I-DNA
activation	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
stimulated	O
with	O
superantigen	O
presented	O
by	O
Raji	B-cell_line
B	I-cell_line
cells	I-cell_line
requires	O
CD28	B-protein
activation	O
.	O

The	O
addition	O
of	O
rCTLA4Ig	O
,	O
which	O
blocks	O
CD28	B-protein
binding	O
to	O
its	O
ligand	O
,	O
to	O
the	O
cultures	O
decreased	O
IL-2	B-DNA
promoter	I-DNA
activation	O
by	O
>	O
80	O
%	O
.	O

Interestingly	O
,	O
CTLA4Ig	O
did	O
not	O
significantly	O
inhibit	O
the	O
activation	O
of	O
either	O
NF	B-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFAT	B-protein
)	O
or	O
AP-1	B-DNA
reporters	I-DNA
.	O

Therefore	O
,	O
activation	O
of	O
NFAT	B-protein
and	O
AP-1	B-protein
is	O
insufficient	O
for	O
IL-2	B-DNA
promoter	I-DNA
activation	O
.	O

In	O
contrast	O
,	O
an	O
RE/AP	B-protein
reporter	O
was	O
blocked	O
by	O
CTLA4Ig	O
by	O
>	O
90	O
%	O
.	O

Thus	O
,	O
the	O
requirement	O
for	O
CD28	B-protein
in	O
IL-2	B-DNA
promoter	I-DNA
activation	O
appears	O
to	O
be	O
due	O
to	O
RE/AP	B-protein
and	O
not	O
the	O
NFAT	B-DNA
or	I-DNA
AP-1	I-DNA
sites	I-DNA
.	O

In	O
addition	O
,	O
these	O
data	O
suggest	O
that	O
transcriptional	O
activation	O
of	O
RE/AP	B-protein
is	O
not	O
mediated	O
by	O
NFAT	B-protein
,	O
because	O
activation	O
of	O
a	O
NFAT	B-protein
reporter	O
is	O
not	O
affected	O
by	O
the	O
addition	O
of	O
CTLA4Ig	O
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Cha	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
T	NULL
‘	NULL
.CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
#	NULL
meJournal	NULL
of	NULL
Cutting	NULL
Edge	NULL
:	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
<	NULL
A	NULL
...	NULL
--	NULL
-	NULL
;	NULL
'Immun010	NULL
gy	NULL
Cells	NULL
and	NULL
AP-1	NULL
Are	NULL
Insufficient	NULL
for	NULL
IL-2	NULL
Promoter	NULL
Activation	NULL
:	NULL
Requirement	NULL
for	NULL
CD28	NULL
Up-Regulation	NULL
of	NULL
RE/AP	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Virginia	NULL
Smith	NULL
Shapiro	NULL
,	NULL
Marianne	NULL
Newton	NULL
Mollenauer	NULL
and	NULL
Arthur	NULL
Weiss	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:6455-6458	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/12/6455	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
21	NULL
articles	NULL
,	NULL
13	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/12/6455	NULL
.	NULL

full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
(	NULL
CTIDG	NULL
€	NULL
=\	NULL
--	NULL
-	NULL
a	NULL
)	NULL
Virginia	NULL
Smith	NULL
Shapiro	NULL
,	NULL
*	NULL
Marianne	NULL
Newton	NULL
Mollenauer	NULL
,	NULL
Cutting	NULL
Edge	NULL
:	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
and	NULL
AP-1	NULL
Are	NULL
Insufficient	NULL
for	NULL
IL-2	NULL
Promoter	NULL
Activation	NULL
:	NULL
Requirement	NULL
for	NULL
CD28	NULL
Up-Regulation	NULL
of	NULL
RE/AP	NULL
!	NULL

7	NULL
and	NULL
Arthur	NULL
Weiss**	NULL
``	NULL
IL-2	NULL
gene	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
both	NULL
TCR	NULL
and	NULL
costimulatory	NULL
signals	NULL
.	NULL

IL-2	NULL
promoter	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
superantigen	NULL
presented	NULL
by	NULL
Raji	NULL
B	NULL
cells	NULL
requires	NULL
CD28	NULL
activation	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
rCTLA4Ig	NULL
,	NULL
which	NULL
blocks	NULL
CD28	NULL
binding	NULL
to	NULL
its	NULL
ligand	NULL
,	NULL
to	NULL
the	NULL
cultures	NULL
decreased	NULL
IL-2	NULL
promoter	NULL
activation	NULL
by	NULL
>	NULL
80	NULL
%	NULL
.	NULL

Interestingly	NULL
,	NULL
CTLA4Ig	NULL
did	NULL
not	NULL
significantly	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
either	NULL
NF	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
or	NULL
AP-1	NULL
reporters	NULL
.	NULL

Therefore	NULL
,	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
is	NULL
insufficient	NULL
for	NULL
IL-2	NULL
promoter	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
RE/AP	NULL
reporter	NULL
was	NULL
blocked	NULL
by	NULL
CTLA4Ig	NULL
by	NULL
>	NULL
90	NULL
%	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
requirement	NULL
for	NULL
CD28	NULL
in	NULL
IL-2	NULL
promoter	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
due	NULL
to	NULL
RE/AP	NULL
and	NULL
not	NULL
the	NULL
NFAT	NULL
or	NULL
AP-1	NULL
sites	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
transcriptional	NULL
activation	NULL
of	NULL
RE/AP	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
NFAT	NULL
,	NULL
because	NULL
activation	NULL
of	NULL
a	NULL
NFAT	NULL
reporter	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CTLA4Ig	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
6455-6458.	NULL
immune	NULL
response	NULL
.	NULL

Minimally	NULL
,	NULL
two	NULL
signals	NULL
are	NULL
required	NULL
to	NULL
convert	NULL
resting	NULL
T	NULL
cells	NULL
into	NULL
effector	NULL
cells	NULL
:	NULL
one	NULL
signal	NULL
through	NULL
the	NULL
TCR	NULL
in	NULL
response	NULL
to	NULL
appropriate	NULL
Ag	NULL
bound	NULL
to	NULL
a	NULL
MHC	NULL
molecule	NULL
,	NULL
and	NULL
a	NULL
second	NULL
``	NULL
costimulatory	NULL
``	NULL
signal	NULL
(	NULL
1	NULL
)	NULL
.	NULL

TCR	NULL
activation	NULL
alone	NULL
may	NULL
result	NULL
in	NULL
a	NULL
state	NULL
of	NULL
unresponsiveness	NULL
or	NULL
anergy	NULL
(	NULL
2	NULL
)	NULL
.	NULL

CD28	NULL
,	NULL
a	NULL
44-kDa	NULL
glycoprotein	NULL
expressed	NULL
as	NULL
a	NULL
homodimer	NULL
on	NULL
most	NULL
T	NULL
cells	NULL
,	NULL
can	NULL
mediate	NULL
the	NULL
costimulatory	NULL
signal	NULL
,	NULL
and	NULL
its	NULL
stimulation	NULL
can	NULL
prevent	NULL
anergy	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
CD28	NULL
binds	NULL
to	NULL
one	NULL
of	NULL
its	NULL
ligands	NULL
,	NULL
B7-1	NULL
and	NULL
B7-2	NULL
,	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
APC	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
CD28-related	NULL
molecule	NULL
,	NULL
CTLA-4	NULL
,	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
B7-1	NULL
and	NULL
B7-2	NULL
,	NULL
but	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
than	NULL
CD28	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Recombinant	NULL
soluble	NULL
CTLA-4	NULL
expressed	NULL
as	NULL
P	NULL
I	NULL
T	NULL
he	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
*Department	NULL
of	NULL
Medicine	NULL
and	NULL
*Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
23	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
October	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
V.S.S	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
the	NULL
Cancer	NULL
Research	NULL
Fund	NULL
of	NULL
the	NULL
Damon	NULL
Runyon-Walter	NULL
Winchell	NULL
Foundation	NULL
DRG-1356	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Arthur	NULL
Weiss	NULL
,	NULL
Box	NULL
0724	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Third	NULL
and	NULL
Parnassus	NULL
Av-enues	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
aweiss	NULL
@	NULL
itsa.ucsf.edu	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
an	NULL
Ig	NULL
fusion	NULL
protein	NULL
,	NULL
CTLA4Ig	NULL
,	NULL
can	NULL
effectively	NULL
block	NULL
CD28-mediated	NULL
signaling	NULL
by	NULL
preventing	NULL
association	NULL
of	NULL
CD28	NULL
with	NULL
its	NULL
ligands	NULL
(	NULL
3	NULL
)	NULL
.	NULL

One	NULL
important	NULL
consequence	NULL
of	NULL
T	NULL
cell	NULL
stimulation	NULL
is	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
due	NULL
to	NULL
both	NULL
transcriptional	NULL
up-regulation	NULL
and	NULL
stabilization	NULL
of	NULL
the	NULL
mRNA	NULL
(	NULL
5	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
induces	NULL
the	NULL
association	NULL
of	NULL
NF	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
``	NULL
AP-1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
to	NULL
sites	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Mutagenesis	NULL
studies	NULL
from	NULL
this	NULL
laboratory	NULL
have	NULL
previously	NULL
revealed	NULL
that	NULL
a	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
located	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
necessary	NULL
for	NULL
CD28-mediated	NULL
transcriptional	NULL
activation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
and	NULL
others	NULL
recently	NULL
showed	NULL
that	NULL
CD28	NULL
responsiveness	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
actually	NULL
conferred	NULL
by	NULL
a	NULL
composite	NULL
element	NULL
(	NULL
``	NULL
RE/AP	NULL
``	NULL
)	NULL
containing	NULL
both	NULL
the	NULL
CD28RE	NULL
and	NULL
adjacent	NULL
NF-IL-2B	NULL
AP-1	NULL
site	NULL
(	NULL
0-11	NULL
)	NULL
.	NULL

The	NULL
CD28RE	NULL
is	NULL
a	NULL
poor	NULL
consensus	NULL
NF-kB	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
,	NULL
primarily	NULL
c-Rel	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
NFAT	NULL
and	NULL
not	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
binds	NULL
to	NULL
the	NULL
CD28RE	NULL
(	NULL
14	NULL
)	NULL
.	NULL

If	NULL
NFAT	NULL
and	NULL
AP-1	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
RE/AP	NULL
site	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
then	NULL
it	NULL
would	NULL
be	NULL
expected	NULL
that	NULL
RE/AP	NULL
should	NULL
be	NULL
activated	NULL
under	NULL
conditions	NULL
where	NULL
both	NULL
NFAT	NULL
and	NULL
AP-1	NULL
are	NULL
up-regulated	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
requires	NULL
both	NULL
TCR	NULL
and	NULL
CD28	NULL
signals	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
NFAT	NULL
and	NULL
AP-1	NULL
activation	NULL
occurs	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
independent	NULL
of	NULL
CD28	NULL
signaling	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
RE/AP	NULL
,	NULL
like	NULL
the	NULL
intact	NULL
IL-2	NULL
promoter	NULL
,	NULL
is	NULL
abrogated	NULL
when	NULL
CD28	NULL
engagement	NULL
is	NULL
blocked	NULL
.	NULL

Therefore	NULL
,	NULL
transcriptional	NULL
regulation	NULL
of	NULL
RE/AP	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
NFAT/AP-1	NULL
family	NULL
members	NULL
,	NULL
because	NULL
RE/AP	NULL
activation	NULL
does	NULL
not	NULL
occur	NULL
when	NULL
both	NULL
NFAT	NULL
and	NULL
AP-1	NULL
are	NULL
up-regulated	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
both	NULL
NFAT	NULL
and	NULL
AP-1	NULL
is	NULL
insufficient	NULL
to	NULL
induce	NULL
IL-2	NULL
promoter	NULL
transcription	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Plasmids	NULL
and	NULL
reagents	NULL
The	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
RE/AP	NULL
luciferase	NULL
reporters	NULL
used	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
luciferase	NULL
construct	NULL
was	NULL
provided	NULL
by	NULL
Gerry	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

CTLA4Ig	NULL
was	NULL
provided	NULL
by	NULL
David	NULL
Daikh	NULL
and	NULL
David	NULL
Wofsy	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
SED	NULL
,	NULL
staphylococcal	NULL
enterotoxin	NULL
D	NULL
;	NULL
SEA	NULL
,	NULL
staphylococcal	NULL
entertoxin	NULL
A	NULL
;	NULL
SEB	NULL
,	NULL
staphylococcal	NULL
entertoxin	NULL
B	NULL
;	NULL
SEC3	NULL
,	NULL
staphylococcal	NULL
entertoxin	NULL
C3	NULL
;	NULL
CD28RE	NULL
,	NULL
CD28	NULL
response	NULL
element	NULL
;	NULL
NFAT	NULL
,	NULL
NF	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6456	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Staphylococcal	NULL
enterotoxin	NULL
E	NULL
(	NULL
SEE	NULL
)	NULL
and	NULL
D	NULL
(	NULL
SED	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Toxin	NULL
Technology	NULL
(	NULL
Sarasota	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

PMA	NULL
and	NULL
iono-mycin	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

C305	NULL
is	NULL
an	NULL
anti-clonotypic	NULL
Ab	NULL
recognizing	NULL
the	NULL
TCR	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

9.3	NULL
is	NULL
a	NULL
mAb	NULL
specific	NULL
for	NULL
human	NULL
CD28	NULL
and	NULL
was	NULL
provided	NULL
by	NULL
Bristol-Myers-Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Division	NULL
(	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
luciferase	NULL
assays	NULL
Jurkat	NULL
transfections	NULL
and	NULL
all	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Transfections	NULL
into	NULL
human	NULL
PBLs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
,	NULL
except	NULL
that	NULL
25	NULL
pug	NULL
of	NULL
either	NULL
RE/AP	NULL
or	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
were	NULL
used	NULL
.	NULL

Briefly	NULL
,	NULL
PBLs	NULL
were	NULL
isolated	NULL
from	NULL
whole	NULL
blood	NULL
by	NULL
Ficoll	NULL
gradient	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
washed	NULL
several	NULL
times	NULL
.	NULL

PBLs	NULL
were	NULL
seeded	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
and	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
PHA	NULL
(	NULL
Abbott	NULL
Laboratories	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
before	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
re-suspended	NULL
at	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
.	NULL

A	NULL
total	NULL
of	NULL
0.25	NULL
ml	NULL
cells	NULL
and	NULL
25	NULL
ug	NULL
DNA	NULL
were	NULL
electroporated	NULL
in	NULL
a	NULL
0.4-cm	NULL
gap	NULL
cuvette	NULL
at	NULL
250	NULL
V	NULL
,	NULL
960	NULL
pF	NULL
,	NULL
using	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Stimulations	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
20-28	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
Raji/SED	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

FK506	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
ng/ml	NULL
and	NULL
was	NULL
added	NULL
to	NULL
the	NULL
Jurkat	NULL
cells	NULL
just	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
Raji/	NULL
SED	NULL
.	NULL

CTLAA4Ig	NULL
or	NULL
control	NULL
Ab	NULL
MOPC195	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
and	NULL
added	NULL
to	NULL
Raji	NULL
cells	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
Jurkat	NULL
cells	NULL
and	NULL
SED	NULL
.	NULL

Then	NULL
,	NULL
16	NULL
h	NULL
after	NULL
stimulation	NULL
by	NULL
Raji/SED	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

Stimulations	NULL
of	NULL
Jurkat	NULL
cells	NULL
by	NULL
€305	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
9.3	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

PBLs	NULL
were	NULL
stimulated	NULL
2	NULL
h	NULL
after	NULL
transfections	NULL
,	NULL
using	NULL
2	NULL
X	NULL
10°	NULL
live	NULL
PBL/	NULL
sample	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
and	NULL
a	NULL
superantigen	NULL
mixture	NULL
containing	NULL
100	NULL
ng/ml	NULL
of	NULL
SEA	NULL
,	NULL
SEB	NULL
,	NULL
and	NULL
SEC3	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Raji	NULL
cells	NULL
,	NULL
preincubation	NULL
with	NULL
CTLA4Ig	NULL
and	NULL
timing	NULL
of	NULL
stimulation	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
described	NULL
are	NULL
the	NULL
result	NULL
of	NULL
three	NULL
independent	NULL
transfections	NULL
.	NULL

All	NULL
p	NULL
values	NULL
were	NULL
determined	NULL
by	NULL
student	NULL
's	NULL
£	NULL
test	NULL
.	NULL

Cell	NULL
staining	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
above	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
stained	NULL
using	NULL
anti-human	NULL
CD69-FITC	NULL
and	NULL
anti-human	NULL
CDS-phycoerythrin	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Jurkat	NULL
,	NULL
but	NULL
not	NULL
Raji	NULL
,	NULL
cells	NULL
expressed	NULL
CD5	NULL
.	NULL

Cells	NULL
were	NULL
gated	NULL
for	NULL
expression	NULL
of	NULL
CD5	NULL
and	NULL
examined	NULL
for	NULL
expression	NULL
of	NULL
CD69	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Cell	NULL
staining	NULL
was	NULL
performed	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
IL-2	NULL
promoter	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
requires	NULL
both	NULL
stimulation	NULL
through	NULL
the	NULL
TCR	NULL
as	NULL
well	NULL
as	NULL
CD28	NULL
costimulation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
to	NULL
secrete	NULL
IL-2	NULL
by	NULL
the	NULL
superantigen	NULL
SED	NULL
presented	NULL
by	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Raji	NULL
(	NULL
8	NULL
,	NULL
19	NULL
)	NULL
.	NULL

We	NULL
wanted	NULL
to	NULL
determine	NULL
the	NULL
requirements	NULL
for	NULL
IL-2	NULL
promoter	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
by	NULL
examining	NULL
the	NULL
activation	NULL
of	NULL
various	NULL
reporter	NULL
constructs	NULL
containing	NULL
transcriptional	NULL
elements	NULL
involved	NULL
in	NULL
IL-2	NULL
promoter	NULL
activation	NULL
,	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
RE/AP	NULL
,	NULL
and	NULL
their	NULL
responses	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CD28	NULL
costimulation	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporters	NULL
containing	NULL
either	NULL
the	NULL
IL-2	NULL
promoter	NULL
or	NULL
multimerized	NULL
copies	NULL
of	NULL
RE/AP	NULL
,	NULL
NFAT	NULL
,	NULL
or	NULL
AP-1	NULL
,	NULL
and	NULL
were	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
,	NULL
SED	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
.	NULL

Incubation	NULL
with	NULL
either	NULL
Raji	NULL
or	NULL
SED	NULL
alone	NULL
was	NULL
insufficient	NULL
for	NULL
activation	NULL
of	NULL
any	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
of	NULL
all	NULL
four	NULL
reporters	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
this	NULL
APC	NULL
and	NULL
SED	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
Raji	NULL
and	NULL
SED	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
activation	NULL
Ag	NULL
CD69	NULL
on	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
a	NULL
different	NULL
superantigen	NULL
,	NULL
SEE	NULL
,	NULL
produced	NULL
similar	NULL
effects	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
CD28	NULL
to	NULL
the	NULL
up-regulation	NULL
of	NULL
each	NULL
of	NULL
these	NULL
reporters	NULL
during	NULL
this	NULL
T	NULL
cell-APC	NULL
interaction	NULL
,	NULL
Raji	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
CTLA4Ig	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SED	NULL
and	NULL
Jurkat	NULL
cells	NULL
to	NULL
the	NULL
cultures	NULL
.	NULL

CTLA4Ig	NULL
recognizes	NULL
the	NULL
same	NULL
ligands	NULL
as	NULL
CD28	NULL
,	NULL
B7-1	NULL
and	NULL
B7-2	NULL
,	NULL
but	NULL
with	NULL
higher	NULL
affinity	NULL
,	NULL
thereby	NULL
CUTTING	NULL
EDGE	NULL
sooB	NULL
s	NULL
S	NULL
co	NULL
&	NULL
im	NULL
0	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
ha	NULL
I	NULL
©	NULL
o	NULL
0	NULL
P	NULL
1	NULL
R	NULL
=	NULL
Ral	NULL
-	NULL
+	NULL
-+	NULL
+O	NULL
-+	NULL
-+	NULL
-+	NULL
-+	NULL
SP	NULL
--	NULL
4+4	NULL
,	NULL
<	NULL
--	NULL
t+4	NULL
--	NULL
t+4	NULL
--	NULL
++	NULL
Luc	NULL
Reporter	NULL
:	NULL
RE/AP	NULL
NFAT	NULL
AP-1	NULL
IL-2	NULL
B	NULL
120	NULL
150	NULL
Counts	NULL
o	NULL
5	NULL
}	NULL
6D	NULL
M	NULL
ait	NULL
0	NULL
agl	NULL
dg	NULL
ocr	NULL
_	NULL
a	NULL
``	NULL
CD69-FITC	NULL
FIGURE	NULL
1	NULL
.	NULL

Both	NULL
Raji	NULL
cells	NULL
and	NULL
SED	NULL
are	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
various	NULL
transcriptional	NULL
reporters	NULL
and	NULL
CD69	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
RE/AP	NULL
,	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
or	NULL
IL-2	NULL
promoter	NULL
luciferase	NULL
reporters	NULL
.	NULL

Approximately	NULL
20-28	NULL
h	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
by	NULL
incubation	NULL
with	NULL
Raji	NULL
B	NULL
cells	NULL
and/or	NULL
superantigen	NULL
SED	NULL
.	NULL

For	NULL
each	NULL
re-porter	NULL
,	NULL
the	NULL
relative	NULL
luciferase	NULL
activity	NULL
was	NULL
standardized	NULL
to	NULL
the	NULL
luciferase	NULL
counts	NULL
when	NULL
stimulated	NULL
with	NULL
both	NULL
Raji	NULL
cells	NULL
and	NULL
SED	NULL
(	NULL
=100	NULL
)	NULL
.	NULL

The	NULL
stimulated	NULL
luciferase	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
is	NULL
not	NULL
equal	NULL
.	NULL

The	NULL
actual	NULL
average	NULL
luciferase	NULL
counts	NULL
for	NULL
the	NULL
Raji/SED	NULL
stimulation	NULL
of	NULL
RE/AP	NULL
is	NULL
21,961	NULL
,	NULL
for	NULL
NFAT	NULL
is	NULL
34,879	NULL
,	NULL
AP-1	NULL
is	NULL
42,003	NULL
,	NULL
and	NULL
for	NULL
IL-2	NULL
9,967	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
reflect	NULL
the	NULL
SE	NULL
of	NULL
the	NULL
means	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
incubated	NULL
with	NULL
Raji	NULL
B	NULL
cells	NULL
and	NULL
superantigen	NULL
SED	NULL
.	NULL

After	NULL
16	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
CDS5-phycoerythrin	NULL
and	NULL
CD69-FITC	NULL
.	NULL

CD5	NULL
is	NULL
present	NULL
on	NULL
Jurkat	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
on	NULL
Raji	NULL
B	NULL
cells	NULL
and	NULL
was	NULL
used	NULL
to	NULL
gate	NULL
for	NULL
CD69	NULL
expression	NULL
only	NULL
on	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
shaded	NULL
area	NULL
reflects	NULL
the	NULL
histogram	NULL
of	NULL
unstimulated	NULL
Ju-rkat	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
is	NULL
the	NULL
histogram	NULL
of	NULL
Jurkat	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
plus	NULL
SED	NULL
.	NULL

blocking	NULL
their	NULL
association	NULL
with	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
CD28	NULL
(	NULL
3	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
CTLA4Ig	NULL
inhibited	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
Raji/SED	NULL
by	NULL
>	NULL
80	NULL
%	NULL
.	NULL

Similarly	NULL
,	NULL
CTLA4Ig	NULL
also	NULL
inhibited	NULL
activation	NULL
of	NULL
the	NULL
RE/AP	NULL
composite	NULL
element	NULL
by	NULL
>	NULL
90	NULL
%	NULL
.	NULL

No	NULL
significant	NULL
effect	NULL
of	NULL
CTLA4Ig	NULL
was	NULL
observed	NULL
on	NULL
either	NULL
the	NULL
NFAT	NULL
or	NULL
AP-1	NULL
reporters	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
or	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
activation	NULL
Ag	NULL
€D69	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CTLA4Ig	NULL
did	NULL
not	NULL
globally	NULL
disrupt	NULL
activation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
by	NULL
Raji/SED	NULL
.	NULL

Identical	NULL
amounts	NULL
of	NULL
an	NULL
irrelevant	NULL
mAb	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
any	NULL
reporter	NULL
or	NULL
CD69	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
CD28	NULL
signaling	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
and	NULL
APC	NULL
.	NULL

Because	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
blockade	NULL
of	NULL
CD28	NULL
,	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
that	NULL
these	NULL
elements	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
defect	NULL
in	NULL
IL-2	NULL
promoter	NULL
transcription	NULL
produced	NULL
by	NULL
the	NULL
block	NULL
of	NULL
the	NULL
CD28-B7	NULL
interaction	NULL
by	NULL
CTLA4Ig	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
activation	NULL
of	NULL
NFAT	NULL
and	NULL
AP-1	NULL
is	NULL
insufficient	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
RE/AP	NULL
composite	NULL
element	NULL
is	NULL
dependent	NULL
on	NULL
CD28	NULL
signaling	NULL
.	NULL

Together	NULL
with	NULL
our	NULL
previous	NULL
studies	NULL
in	NULL
which	NULL
the	NULL
CD28RE	NULL
was	NULL
mutated	NULL
(	NULL
8	NULL
)	NULL
,	NULL
we	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
w	NULL
im	NULL
C	NULL
ba	NULL
o	NULL
5	NULL
80	NULL
60	NULL
40	NULL
20	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
0	NULL
em	NULL
-	NULL
4+	NULL
44+	NULL
-+++	NULL
SED	NULL
-+	NULL
+	NULL
-	NULL
+++	NULL
CTLA4lg	NULL
_	NULL
_	NULL
p	NULL
ooo	NULL
Control	NULL
Ab	NULL
(	NULL
-	NULL
-	NULL
-	NULL
<	NULL
A	NULL
-	NULL
-=	NULL
--	NULL
t	NULL
,	NULL
Luc	NULL
Reporter	NULL
:	NULL
-	NULL
RE/AP	NULL
NFAT	NULL
__	NULL
.	NULL

AP1	NULL
IL-2	NULL
B	NULL
120	NULL
150	NULL
Counts	NULL
do	NULL
&	NULL
)	NULL
600	NULL
M	NULL
10°	NULL
0	NULL
ad	NULL
0	NULL
n	NULL
``	NULL
CD69-FITC	NULL
FIGURE	NULL
2	NULL
.	NULL

CTLA4Ig	NULL
blocks	NULL
activation	NULL
of	NULL
RE/AP	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
Raji/SED	NULL
stimulation	NULL
.	NULL

A	NULL
,	NULL
Transfections	NULL
and	NULL
stimulations	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
except	NULL
that	NULL
in	NULL
some	NULL
cultures	NULL
,	NULL
as	NULL
denoted	NULL
in	NULL
the	NULL
figure	NULL
,	NULL
the	NULL
Raji	NULL
B	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
either	NULL
CTLA4Ig	NULL
or	NULL
a	NULL
control	NULL
mAb	NULL
,	NULL
MOPC195	NULL
,	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SED	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
reflect	NULL
the	NULL
SE	NULL
of	NULL
the	NULL
means	NULL
.	NULL

B	NULL
,	NULL
Stimulations	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
except	NULL
that	NULL
the	NULL
Raji	NULL
B	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
either	NULL
CTLA4Ig	NULL
or	NULL
an	NULL
irrelevant	NULL
control	NULL
mAb	NULL
,	NULL
MOPC195	NULL
,	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
SED	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
shaded	NULL
area	NULL
reflects	NULL
the	NULL
histogram	NULL
of	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
is	NULL
the	NULL
histogram	NULL
of	NULL
Jurkat	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
plus	NULL
SED	NULL
.	NULL

The	NULL
dashed	NULL
line	NULL
is	NULL
the	NULL
histogram	NULL
of	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
,	NULL
SED	NULL
,	NULL
and	NULL
CTLA4Ig	NULL
.	NULL

The	NULL
dotted	NULL
line	NULL
is	NULL
the	NULL
histogram	NULL
of	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
,	NULL
SED	NULL
,	NULL
and	NULL
a	NULL
control	NULL
Ab	NULL
.	NULL

1g	NULL
``	NULL
conclude	NULL
that	NULL
RE/AP	NULL
is	NULL
the	NULL
critical	NULL
element	NULL
within	NULL
the	NULL
IL-2	NULL
promoter	NULL
that	NULL
is	NULL
activated	NULL
by	NULL
CD28	NULL
and	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
by	NULL
superantigen	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
because	NULL
RE/AP	NULL
activation	NULL
was	NULL
blocked	NULL
by	NULL
CTLA4Ig	NULL
even	NULL
though	NULL
NFAT	NULL
and	NULL
AP-1	NULL
reporters	NULL
were	NULL
unaffected	NULL
,	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
that	NULL
activation	NULL
of	NULL
RE/AP	NULL
is	NULL
mediated	NULL
by	NULL
NFAT/AP-1	NULL
as	NULL
had	NULL
been	NULL
previously	NULL
proposed	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Rather	NULL
,	NULL
these	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
findings	NULL
that	NULL
RE/AP	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
c-Rel	NULL
and	NULL
AP-1	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
a	NULL
major	NULL
role	NULL
for	NULL
RE/AP	NULL
activation	NULL
in	NULL
IL-2	NULL
promoter	NULL
regulation	NULL
,	NULL
the	NULL
c-Rel	NULL
knockout	NULL
mouse	NULL
is	NULL
defective	NULL
in	NULL
IL-2	NULL
production	NULL
in	NULL
response	NULL
to	NULL
CD3/CD28	NULL
stimulation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
findings	NULL
that	NULL
RE/AP	NULL
and	NULL
NFAT	NULL
differ	NULL
in	NULL
their	NULL
requirement	NULL
for	NULL
CD28	NULL
activation	NULL
were	NULL
confirmed	NULL
by	NULL
transfecting	NULL
normal	NULL
human	NULL
PBLs	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
15	NULL
)	NULL
,	NULL
the	NULL
transcriptional	NULL
response	NULL
of	NULL
PBLs	NULL
stimulated	NULL
by	NULL
a	NULL
pool	NULL
of	NULL
three	NULL
staphylococcal	NULL
enterotoxins	NULL
presented	NULL
by	NULL
Raji	NULL
cells	NULL
can	NULL
be	NULL
monitored	NULL
with	NULL
reporter	NULL
constructs	NULL
.	NULL

Stimulation	NULL
with	NULL
enterotoxins	NULL
presented	NULL
by	NULL
Raji	NULL
B	NULL
cells	NULL
activated	NULL
RE/AP	NULL
and	NULL
NFAT	NULL
reporter	NULL
constructs	NULL
by	NULL
22-	NULL
and	NULL
23-fold	NULL
,	NULL
respec-tively	NULL
.	NULL

RE/AP	NULL
activation	NULL
in	NULL
PBLs	NULL
stimulated	NULL
by	NULL
enterotoxins	NULL
presented	NULL
by	NULL
Raji	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
almost	NULL
two-thirds	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CTLA4Ig	NULL
to	NULL
the	NULL
culture	NULL
(	NULL
62.0	NULL
+	NULL
1.3	NULL
%	NULL
)	NULL
.	NULL

Significantly	NULL
less	NULL
inhibition	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
response	NULL
was	NULL
observed	NULL
when	NULL
CTLA4lg	NULL
was	NULL
added	NULL
(	NULL
30.5	NULL
+	NULL
3.3	NULL
%	NULL
;	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
a	NULL
6457	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
0	NULL
1	NULL
-=-	NULL
Inc	NULL
Raji/SED	NULL
-	NULL
+	NULL
+	NULL
FK506	NULL
-_	NULL
-	NULL
4	NULL
Luc	NULL
Reporter	NULL
:	NULL
-	NULL
RE/AP	NULL
B	NULL
{	NULL
a	NULL
w	NULL
43	NULL
g	NULL
3	NULL
e	NULL
]	NULL
\	NULL
o	NULL
30	NULL
6D	NULL
M	NULL
17	NULL
0	NULL
ao	NULL
_	NULL
a	NULL
``	NULL
5	NULL
<	NULL
CD69-FITC	NULL
FIGURE	NULL
3	NULL
.	NULL

FK506	NULL
blocks	NULL
activation	NULL
of	NULL
RE/AP	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
Raji/SED	NULL
.	NULL

A	NULL
,	NULL
Transfections	NULL
and	NULL
stimulation	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
except	NULL
that	NULL
FK506	NULL
was	NULL
added	NULL
to	NULL
some	NULL
cultures	NULL
as	NULL
denoted	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
reflect	NULL
the	NULL
SE	NULL
of	NULL
the	NULL
means	NULL
.	NULL

B	NULL
,	NULL
Stimulations	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
except	NULL
that	NULL
FK506	NULL
was	NULL
added	NULL
to	NULL
some	NULL
cultures	NULL
.	NULL

The	NULL
shaded	NULL
area	NULL
reflects	NULL
the	NULL
histogram	NULL
of	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
solid	NULL
line	NULL
is	NULL
the	NULL
histogram	NULL
of	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
plus	NULL
SED	NULL
.	NULL

The	NULL
dotted	NULL
line	NULL
is	NULL
the	NULL
histogram	NULL
of	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
Raji	NULL
cells	NULL
,	NULL
SED	NULL
,	NULL
and	NULL
FK506	NULL
.	NULL

control	NULL
Ab	NULL
did	NULL
not	NULL
affect	NULL
either	NULL
RE/AP	NULL
or	NULL
NFAT	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
findings	NULL
with	NULL
normal	NULL
PBLs	NULL
support	NULL
our	NULL
data	NULL
obtained	NULL
with	NULL
Jurkat	NULL
cells	NULL
;	NULL
RE/AP	NULL
is	NULL
not	NULL
a	NULL
NFAT	NULL
site	NULL
,	NULL
and	NULL
it	NULL
is	NULL
the	NULL
major	NULL
site	NULL
of	NULL
CD28	NULL
activation	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

We	NULL
should	NULL
note	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
RE/AP	NULL
by	NULL
CTLA4Ig	NULL
was	NULL
not	NULL
as	NULL
complete	NULL
in	NULL
normal	NULL
PBLs	NULL
as	NULL
was	NULL
observed	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
may	NULL
relate	NULL
to	NULL
the	NULL
prestimulation	NULL
that	NULL
must	NULL
be	NULL
used	NULL
to	NULL
render	NULL
the	NULL
PBL	NULL
s	NULL
transfectable	NULL
with	NULL
the	NULL
DNA	NULL
reporter	NULL
constructs	NULL
.	NULL

They	NULL
must	NULL
be	NULL
prestimulated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
mitogenic	NULL
concentrations	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
of	NULL
PHA	NULL
before	NULL
transfection	NULL
.	NULL

This	NULL
may	NULL
alter	NULL
the	NULL
requirements	NULL
for	NULL
costimulation	NULL
after	NULL
transfection	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
the	NULL
background	NULL
luciferase	NULL
activity	NULL
of	NULL
RE/AP	NULL
in	NULL
PBLs	NULL
is	NULL
considerably	NULL
higher	NULL
than	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
~6400	NULL
in	NULL
PBLs	NULL
compared	NULL
with	NULL
~400	NULL
in	NULL
Jurkat	NULL
cells	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
there	NULL
may	NULL
be	NULL
additional	NULL
costimulatory	NULL
molecules	NULL
present	NULL
and	NULL
activated	NULL
on	NULL
PBLs	NULL
as	NULL
compared	NULL
with	NULL
Jurkat	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
PBLs	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
data	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
RE/AP	NULL
is	NULL
different	NULL
from	NULL
NFAT	NULL
and	NULL
is	NULL
the	NULL
major	NULL
site	NULL
of	NULL
CD28	NULL
costimulation	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Activation	NULL
of	NULL
RE/AP	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
required	NULL
CD28	NULL
signaling	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
data	NULL
suggested	NULL
that	NULL
RE/AP	NULL
was	NULL
a	NULL
site	NULL
of	NULL
signal	NULL
integration	NULL
in	NULL
T	NULL
cells	NULL
;	NULL
any	NULL
pairwise	NULL
combination	NULL
of	NULL
either	NULL
TCR	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
PMA	NULL
can	NULL
be	NULL
used	NULL
to	NULL
activate	NULL
RE/AP-depen-dent	NULL
transcription	NULL
(	NULL
11	NULL
)	NULL
.	NULL

TCR-mediated	NULL
activation	NULL
of	NULL
RE/AP	NULL
is	NULL
sensitive	NULL
to	NULL
inhibition	NULL
by	NULL
the	NULL
calcineurin	NULL
inhibitor	NULL
FK506	NULL
,	NULL
while	NULL
CD28-mediated	NULL
activation	NULL
of	NULL
RE/AP	NULL
is	NULL
resistence	NULL
to	NULL
FK506	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
RE/AP	NULL
also	NULL
integrates	NULL
signals	NULL
through	NULL
the	NULL
TCR	NULL
in	NULL
a	NULL
physiological	NULL
response	NULL
to	NULL
superantigen	NULL
,	NULL
FK506	NULL
was	NULL
used	NULL
in	NULL
the	NULL
Raji/SED	NULL
system	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
FK506	NULL
blocked	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6458	NULL
activation	NULL
of	NULL
RE/AP	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
Raji/SED	NULL
almost	NULL
completely	NULL
(	NULL
>	NULL
95	NULL
%	NULL
inhibition	NULL
)	NULL
.	NULL

However	NULL
,	NULL
activation	NULL
of	NULL
AP-1	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
remained	NULL
intact	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
although	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
been	NULL
inhibited	NULL
,	NULL
Jurkat	NULL
cell	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
has	NULL
not	NULL
been	NULL
globally	NULL
interrupted	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
a	NULL
response	NULL
to	NULL
a	NULL
physiological	NULL
stimulus	NULL
,	NULL
SED	NULL
superantigen	NULL
presented	NULL
by	NULL
Raji	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
RE/AP	NULL
minimally	NULL
requires	NULL
two	NULL
signals	NULL
:	NULL
one	NULL
through	NULL
the	NULL
TCR	NULL
as	NULL
demonstrated	NULL
by	NULL
inhibition	NULL
by	NULL
FK506	NULL
and	NULL
the	NULL
second	NULL
through	NULL
CD28	NULL
as	NULL
demonstrated	NULL
by	NULL
inhibition	NULL
by	NULL
CTLA4Ig	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
CTLA4Ig	NULL
specifically	NULL
interrupted	NULL
only	NULL
CD28	NULL
signals	NULL
,	NULL
presumably	NULL
leaving	NULL
other	NULL
adhesive	NULL
and	NULL
costimulatory	NULL
interactions	NULL
between	NULL
the	NULL
Jurkat	NULL
T	NULL
and	NULL
Raji	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
during	NULL
Ag	NULL
presentation	NULL
intact	NULL
,	NULL
including	NULL
LFA-1/ICAM	NULL
,	NULL
LFA-2/	NULL
LFA-3	NULL
,	NULL
etc	NULL
.	NULL

However	NULL
,	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
that	NULL
these	NULL
molecules	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
can	NULL
compensate	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
CD28	NULL
signaling	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
studies	NULL
that	NULL
demonstrated	NULL
a	NULL
central	NULL
role	NULL
for	NULL
CD28	NULL
stimulation	NULL
in	NULL
IL-2	NULL
production	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
data	NULL
do	NULL
not	NULL
preclude	NULL
the	NULL
notion	NULL
that	NULL
other	NULL
costimulatory	NULL
pathways	NULL
(	NULL
not	NULL
present	NULL
or	NULL
activated	NULL
between	NULL
Raji	NULL
B	NULL
cells	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
)	NULL
exist	NULL
that	NULL
can	NULL
substitute	NULL
for	NULL
CD28	NULL
engagement	NULL
for	NULL
RE/AP	NULL
and	NULL
IL-2	NULL
promoter	NULL
activation	NULL
.	NULL

Alternate	NULL
mechanisms	NULL
for	NULL
activation	NULL
of	NULL
RE/AP	NULL
are	NULL
currently	NULL
under	NULL
investigation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Keith	NULL
Yamamoto	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Weiss	NULL
laboratory	NULL
for	NULL
thoughtful	NULL
discussion	NULL
of	NULL
the	NULL
data	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Mike	NULL
Shapiro	NULL
for	NULL
statisical	NULL
analyses	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Chambers	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1997	NULL
.	NULL

Co-stimulation	NULL
in	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immumol	NULL
.	NULL

9:396	NULL
.	NULL

2	NULL
.	NULL

Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
1997	NULL
.	NULL

T	NULL
cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:351	NULL
.	NULL

3	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Ammu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233	NULL
.	NULL

4	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B7	NULL
and	NULL
CD28	NULL
receptor	NULL
families	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:321	NULL
.	NULL

5	NULL
.	NULL

Umlauf	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
S.-M.	NULL
Kang	NULL
,	NULL
K.	NULL
Brorson	NULL
,	NULL
A.-C.	NULL
Tran	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
:	NULL
rheostatic	NULL
control	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

133:177	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

CUTTING	NULL
EDGE	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Loh	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333.	NULL
.	NULL

Riegel	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
W.	NULL
M.	NULL
Flanagan	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Chem	NULL
.	NULL

Immunol	NULL
.	NULL

51:266.	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
251:313.	NULL
.	NULL

Butscher	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
C.	NULL
Powers	NULL
,	NULL
M.	NULL
Olive	NULL
,	NULL
C.	NULL
Vinson	NULL
,	NULL
and	NULL
K.	NULL
Gardner	NULL
.	NULL

1998	NULL
.	NULL

Coor-	NULL
dinate	NULL
transactivation	NULL
of	NULL
the	NULL
interleukin-2	NULL
response	NULL
element	NULL
by	NULL
c-Rel	NULL
and	NULL
ATF-1/CREB2	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:552	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Iacobelli	NULL
.	NULL

1997	NULL
.	NULL

Involvement	NULL
of	NULL
Rel	NULL
,	NULL
Fos	NULL
,	NULL
and	NULL
Jun	NULL
proteins	NULL
in	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
CD28	NULL
response	NULL
element/AP-1	NULL
sequence	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:1319	NULL
.	NULL

Shapiro	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
K.	NULL
E.	NULL
Truitt	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1997	NULL
.	NULL

CD28	NULL
mediates	NULL
transcriptional	NULL
upregulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
promoter	NULL
through	NULL
a	NULL
composite	NULL
element	NULL
containing	NULL
the	NULL
CD28RE	NULL
and	NULL
NF-IL-2B	NULL
AP-1	NULL
sites	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:4051	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
and	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1696	NULL
.	NULL

Lai	NULL
,	NULL
J.-H.	NULL
,	NULL
G.	NULL
Horvath	NULL
,	NULL
J.	NULL
Subleski	NULL
,	NULL
J.	NULL
Bruder	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
and	NULL
T.-H.	NULL
Tan	NULL
.	NULL

1995	NULL
.	NULL

RelA	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
within	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4260	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
M.	NULL
E.	NULL
Newton	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

CD28	NULL
and	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
coordinately	NULL
regulate	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
superantigen	NULL
stimulation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1131	NULL
.	NULL

Shapiro	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
M.	NULL
N.	NULL
Mollenauer	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1996.	NULL
c-Rel	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
may	NULL
be	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
AP-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1663	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1984	NULL
.	NULL

Requirement	NULL
for	NULL
the	NULL
coexpression	NULL
of	NULL
T3	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
on	NULL
a	NULL
malignant	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

137:1284	NULL
.	NULL

Hughes	NULL
,	NULL
C.	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:5369	NULL
.	NULL

Herman	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Croteau	NULL
,	NULL
R.	NULL
P.	NULL
Sekaly	NULL
,	NULL
J.	NULL
Kappler	NULL
,	NULL
and	NULL
P.	NULL
Marrack	NULL
.	NULL

1990	NULL
.	NULL

HLA-DR	NULL
alleles	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
present	NULL
staphylococcal	NULL
enterotoxins	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:709	NULL
.	NULL

Kontgen	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
J.	NULL
Grumont	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
D.	NULL
Tarlinton	NULL
,	NULL
and	NULL
S.	NULL
Gerondakis	NULL
.	NULL

1995	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
exhibit	NULL
defects	NULL
in	NULL
lymphocyte	NULL
proliferation	NULL
,	NULL
humoral	NULL
immunity	NULL
,	NULL
and	NULL
interleukin-2	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:19635	NULL
.	NULL

Green	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
A.	NULL
I.	NULL
Sperling	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
G.	NULL
S.	NULL
Gray	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1994	NULL
.	NULL

Absence	NULL
of	NULL
B7-dependent	NULL
responses	NULL
in	NULL
CD28-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
1:501	NULL
.	NULL

Shahinian	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Pfeffer	NULL
,	NULL
K.	NULL
P.	NULL
Lee	NULL
,	NULL
T.	NULL
M.	NULL
Kundig	NULL
,	NULL
K.	NULL
Kishihara	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
K.	NULL
Kawai	NULL
,	NULL
P.	NULL
S.	NULL
Ohashi	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
T	NULL
cell	NULL
costimulatory	NULL
requirements	NULL
in	NULL
CD28-deficient	NULL
mice	NULL
.	NULL

Science	NULL
261:609	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

